Since overhauling the federal cannabis license application process in May, Health Canada completed about three-quarters of the eligible high-level reviews in the licensing queue as of the end of June. But some industry sources say the regulatory agency is not moving...
CannTrust Holdings halted all sales of cannabis products while Canada’s federal regulator inspects its Vaughan, Ontario, manufacturing facility.
New Zealand released highly anticipated proposed medical cannabis regulations Wednesday, representing a “huge milestone” for the country’s burgeoning industry as it looks to become a hub for innovation, cultivation and production, industry sources said.
Beleaguered cannabis grower CannTrust shipped some unlicensed medical cannabis overseas, the Ontario company told Marijuana Business Daily, adding an international dimension to the Canadian company’s regulatory woes.
Ontario-based licensed cannabis grower CannTrust was sanctioned by Health Canada for conducting unlicensed cultivation for six months and providing inaccurate information to the federal regulator.
Licensed growers who want to sell cannabis clones in British Columbia are going to have to wait – or look to other markets – because the provincial wholesaler has neither immediate plans nor the ability to distribute those products to retailers.
Ontario’s plan to belatedly add more cannabis stores to its underwhelming roster of 23 authorizations is a sign the government is listening to industry and consumer feedback that the market can sustain – and requires – more outlets, according to experts.
Canadian cannabis producer Canopy Growth on Wednesday announced the departure of Bruce Linton as co-chief executive, a surprise move that analysts say could be tied to the company's disappointing earnings. Effective immediately, Linton is stepping down and co-CEO Mark...
Health Canada handed out three noncompliant ratings to cannabis producers from the nearly 260 inspections the federal regulator conducted in the last fiscal year, according to its recently released compliance report.
U.S. cannabis companies needing to raise a large pot of capital can’t list on the New York Stock Exchange or the Nasdaq. Both exchanges continue to bar U.S. plant-touching companies. Blame it on the federal government’s ban on marijuana. The Canadian Securities...
Ireland is embarking on a five-year medical cannabis pilot program, opening up commercial opportunities for companies to supply the Irish market once their products have met approval requirements set out in legislation. The cannabis products will be dispensed from...
Switzerland is looking to give physicians the ability to prescribe cannabis-based medicines, which would significantly boost access and, if approved, create one of Europe’s newest regulated markets.
